Healthcare conglomerate specializing in pharmaceuticals, medical devices, and consumer health products with trusted global brands.
Profile & Fundamentals
Review the profile, reported financial history, AI financial assessment, dividends, splits, and dated events for Johnson & Johnson.
Profile & Fundamentals
Johnson & Johnson Profile & Fundamentals
Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.
Explore this pageJump to a Profile & Fundamentals section
Explore this research
Profile & Fundamentals contents
Jump directly to any section
Company and Market Context
Company Profile & Ownership
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Company profile record
Johnson & Johnson
Common Stock · Healthcare · Drug Manufacturers - General
Company
- Company / asset
- Johnson & Johnson
- Security type
- Common Stock
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- HQ
- 🇺🇸 United States
- Head office
- One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
Leadership & scale
- Chief executive
- Mr. Joaquin Duato
- CEO year born
- 1963
- Full-time employees
- 138.2K
- Fiscal year end
- December
- IPO date
- 1944-09-24
Fundamentals snapshot
- Market Cap
- USD 625.5B
- P/E
- 29.7x
- Revenue (Q2 26)
- USD 25.3B
- Profit (Q2 26)
- USD 5.5B
- Dividend Yield
- 1.4%
- Revenue (FY 25)
- USD 94.2B
- Shares in public float
- 2.4B
- Insider ownership
- 0.05%
Reporting & identifiers
- Symbol
- JNJ.NYSE
- Listing
- 🇺🇸 United States | Dividend Tax: 30%
- Ticker Currency
- USD
- Income Statement Currency
- USD
- Balance Sheet Currency
- USD
- Cash Flow Currency
- USD
- EPS Currency
- USD
- Contract Type
- SPOT
- ISIN
- US4781601046
- Asset ID
- equity_c3269539-01b8-5845-8971-363e7e618c20
Ownership
Shares Outstanding
Latest: 2.4B | Max: 2.9B | Min: 2.4B
Complete Research Workspace
Unlock the complete Profile & Fundamentals
Sign in to verify your access, or upgrade to the Base plan to open every chart, financial statement, event, and source table.